Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Integrin Alpha-v-Beta 6 in Pancreatic Cancer With [18F]-R01-MG-F2: a First in Human Study

NCT02683824 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02683824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02683824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Integrin Alpha-v-Beta 6 in Pancreatic Cancer With [18F]-R01-MG-F2: a First in Human Study
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
January 12, 2016
Completion date
December 1, 2022
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subject, pancreatic carcinoma